MG
NVAX icon

Michael Gelband’s Novavax NVAX Stock Holding History

Michael Gelband’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Sell
10,931
-46,019
-81% -$412K ﹤0.01% 1462
2026
Q1 		$464K Buy
+56,950
New +$516K ﹤0.01% 1211
2025
Q4 		– Sell
-29,865
Closed -$259K – 1908
2025
Q3 		$259K Buy
+29,865
New +$232K ﹤0.01% 1336
2025
Q2 		– Sell
-80,815
Closed -$518K – 1823
2025
Q1 		$518K Sell
80,815
-253,331
-76% -$2.09M 0.01% 1106
2024
Q4 		$2.69M Buy
+334,146
New +$3.22M 0.02% 611
2023
Q3 		– Sell
-34,412
Closed -$256K – 2001
2023
Q2 		$256K Buy
+34,412
New +$271K ﹤0.01% 1604
2022
Q4 		– Sell
-25,534
Closed -$465K – 1972
2022
Q3 		$465K Buy
25,534
+4,238
+20% +$184K 0.01% 1393
2022
Q2 		$1.09M Buy
21,296
+14,487
+213% +$750K 0.01% 1042
2022
Q1 		$501K Buy
6,809
+3,736
+122% +$333K 0.01% 1514
2021
Q4 		$440K Buy
3,073
+90
+3% +$15.5K ﹤0.01% 1486
2021
Q3 		$618K Buy
2,983
+1,168
+64% +$257K 0.01% 1271
2021
Q2 		$385K Sell
1,815
-12,780
-88% -$2.34M ﹤0.01% 1585
2021
Q1 		$2.65M Buy
+14,595
New +$2.91M 0.04% 466
2020
Q4 		– Sell
-7,143
Closed -$774K – 2257
2020
Q3 		$774K Sell
7,143
-2,280
-24% -$278K 0.02% 795
2020
Q2 		$785K Buy
+9,423
New +$360K 0.02% 864
2019
Q4 		– Sell
-10,700
Closed -$54K – 1776
2019
Q3 		$54K Buy
+10,700
New +$58.6K ﹤0.01% 1276

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Michael Gelband's NVAX Position: Q2 2026 in Review

Michael Gelband reduced its Novavax (NVAX) stake by 81% in Q2 2026, selling an estimated $412K and leaving 10,931 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1462.

Michael Gelband first reported a position in NVAX in Q3 2019 and has held it in 16 quarters since. The position peaked at $2.69M in Q4 2024. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Michael Gelband held 10,931 shares of Novavax worth $103K as of Q2 2026.
  • Michael Gelband sold 46,019 Novavax shares in Q2 2026, an estimated $412K.
  • Novavax made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1462 holding.
  • Michael Gelband first reported a position in Novavax in Q3 2019 and has held it in 16 quarters since.
  • Michael Gelband's Novavax position peaked at $2.69M in Q4 2024.
  • 264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.